-
eTMF Governance Models for Sponsors and CROs: A Practical Guide
When a sponsor delegates elements of a clinical trial to a CRO, a critical operational question arises: "Who is responsible for the Trial Master File?" An eTMF governance model for sponsors and CROs provides the formal answer. It is the documented framework that dictates how the TMF will be controlled, managed, and overseen by both
-
Mastering TMF Quality Control and Ongoing Oversight for Compliant Clinical Trials
Effective TMF quality control and ongoing oversight is a foundational component of an inspection-ready clinical trial. The objective is not merely to collect documents but to establish and maintain a system that demonstrates the integrity of a trial’s conduct from initiation to final submission. A well-defined quality program provides assurance that trial data is verifiable
-
Trial Master File Completeness and Inspection Readiness: A Practical GCP Guide
Maintaining the Trial Master File (TMF) in a state of completeness and inspection readiness is a continuous operational discipline throughout the clinical trial lifecycle. The objective is to manage the TMF actively so that it is complete, timely, and of high quality at any given moment. This proactive approach ensures the study's conduct can be
-
A Guide to Statistical Analysis Plan Lifecycle Management
Effective management of a Statistical Analysis Plan (SAP) lifecycle is a systematic process governing the document from initial draft to final archival. This framework is foundational for ensuring regulatory compliance and the scientific validity of a clinical trial. A well-managed lifecycle creates a transparent, controlled, and prospectively defined plan for the analysis of trial data.
-
Mastering Investigator’s Brochure Updates and Documentation Control
Maintaining a current Investigator’s Brochure (IB) is a fundamental component of ensuring clinical trial safety. The IB is a dynamic document that must evolve to reflect new clinical and nonclinical data gathered about an investigational product. This systematic process is a regulatory requirement and essential for trial integrity. The Critical Role of IB Updates and